Saitama, Japan

Takaya Osawa

This inventor holds 2 USPTO granted patents. Top assignee: Hitachi Medical Corporation. Active years: 2004-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takaya Osawa. Retrieved from https://idiyas.com/inventor/takaya-osawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 81(Granted Patents)


Location History:

  • Sugito-machi, JP (2004)
  • Saitama, JP (2008)

Company Filing History:


Years Active: 2004-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takaya Osawa: Pioneering Inventor from Saitama, JP

Introduction: Takaya Osawa is a renowned inventor hailing from Saitama, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Osawa's latest patents focus on advancements in robotics and artificial intelligence, showcasing his dedication to pushing the boundaries of modern technology.

Career Highlights: With a career spanning over two decades, Osawa has worked with leading tech companies in Japan, spearheading projects that have revolutionized the industry. His innovative solutions have earned him recognition both nationally and internationally.

Collaborations: Throughout his career, Osawa has collaborated with top researchers, engineers, and scientists to bring his ideas to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge technologies.

Conclusion: Takaya Osawa's passion for innovation and his relentless drive to create have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors and technologists.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…